Pharmaceuticals & Biotech — Global Regulatory Expertise
Global Regulatory Coverage
Pharmaceuticals & Biotech — Global Regulatory Expertise
Regulatory strategy, compliance programs, and submission support for pharmaceutical and biotechnology products across FDA, EMA, Health Canada, TGA, and international markets.
Pharmaceutical and biotechnology products face the most complex and demanding regulatory requirements of any product category — and those requirements vary significantly across markets. A regulatory strategy that works for FDA may not work for EMA, and a submission that succeeds in the US may require substantial adaptation for Canada or Australia. Tomorrow's Crop provides pharmaceutical and biotech regulatory consulting that navigates this complexity — building global regulatory strategies that are efficient, defensible, and aligned with your development and commercial timelines.
What We Do
A detailed breakdown of our capabilities in this practice area.
Global Regulatory Strategy
Global regulatory strategy for pharmaceutical and biotech products — defining the optimal sequence for international market entry, harmonizing development activities across markets, and minimizing duplicative regulatory work.
FDA Drug Regulatory Affairs
FDA regulatory affairs for pharmaceutical products — including IND strategy, NDA/ANDA/BLA preparation, pre-submission meetings, and post-approval compliance.
EMA Regulatory Affairs
EMA regulatory affairs for pharmaceutical and biotech products — including centralized procedure strategy, MAA preparation, and post-authorization compliance.
CMC Regulatory Support
Chemistry, manufacturing, and controls (CMC) regulatory support — including drug substance and drug product characterization, manufacturing process description, and analytical method documentation for regulatory submissions.
Biosimilar Regulatory Strategy
Regulatory strategy for biosimilar development — including reference product selection, comparability study design, and submission strategy for FDA 351(k) and EMA biosimilar applications.
Combination Product Regulatory Affairs
Regulatory affairs for drug-device and drug-biologic combination products — including primary mode of action determination, lead center assignment, and submission strategy.
Post-Market Compliance
Post-market compliance for approved pharmaceutical and biotech products — including adverse event reporting, labeling updates, annual reporting, and post-approval change management.
Regulatory Intelligence
Pharmaceutical regulatory intelligence — monitoring FDA, EMA, and international regulatory developments relevant to your products and pipeline.
How We Work
Product & Market Assessment
We assess your product, development stage, and target markets — defining the regulatory landscape and identifying the key regulatory requirements for each market.
Global Strategy Development
We develop a global regulatory strategy — defining the optimal sequence for market entry, harmonizing development activities, and identifying opportunities to leverage regulatory work across markets.
Submission Planning
We develop submission plans for each target market — defining content requirements, timelines, and resource needs.
Submission Preparation & Support
We prepare or support preparation of regulatory submissions — writing regulatory sections, compiling data, and managing the submission process.
Post-Submission Management
We manage post-submission interactions — responding to agency questions, preparing for agency meetings, and supporting approval and post-approval compliance.
Outcomes You Can Expect
Why Tomorrow's Crop
Pharmaceutical and biotech regulatory affairs requires deep expertise in both the science and the regulatory process — and the experience to navigate the differences between FDA, EMA, and other major regulatory agencies. Our pharmaceutical regulatory consultants have managed regulatory programs for small molecules, biologics, and biosimilars across global markets.
Deepen Your Knowledge
Insights, ready-to-use documents, and training programs related to this practice area.
Insights
- Building a QMS for a Regulated Startup
- Understanding FDA Inspection Priorities in 2026
- GMP Fundamentals: What Every Food Manufacturer Needs to Know
Document Resources
- NDA/ANDA CMC Section GuideTC-REG-SPEC-005
- International Regulatory Strategy ToolkitTC-REG-ADV-003
- Pre-Submission Meeting Preparation GuideTC-REG-ADV-002
- Regulatory Strategy & Pathway Assessment FrameworkTC-REG-FUND-001
Ready to move forward?
Schedule a discovery call and let's define the right engagement for your organization.